Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
about
Update of the human and mouse SERPIN gene superfamilyMice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injuryUnderstanding Dermatan Sulfate-Heparin Cofactor II Interaction through Virtual Library ScreeningUnique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.Loss of dermatan-4-sulfotransferase 1 function results in adducted thumb-clubfoot syndrome.Thrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces.Differentiating chondroitin sulfate glycosaminoglycans using collision-induced dissociation; uronic acid cross-ring diagnostic fragments in a single stage of tandem mass spectrometry.Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice.Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor IIA guide to murine coagulation factor structure, function, assays, and genetic alterations.CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas.Thrombin-targeted liposomes establish a sustained localized anticlotting barrier against acute thrombosis.Marine medicinal glycomics.Specific sulfation and glycosylation-a structural combination for the anticoagulation of marine carbohydrates.Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin.Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis.Mass Spectrometry-Based (GeLC-MS/MS) Comparative Proteomic Analysis of Endoscopically (ePFT) Collected Pancreatic and Gastroduodenal Fluids.In vitro and in vivo effects of hemodilution on kaolin-based activated clotting time predicted heparin requirement using a heparin dose-response technique.Diagnosis of LVAD Thrombus using a High-Avidity Fibrin-Specific 99mTc Probe.Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice
P2860
Q24622280-D4D8B05F-55A4-486C-ABEC-4149E5E9DEA7Q28506928-C5CAF3A1-17C3-4417-87E9-C59C864B851CQ33690582-D47B5B16-5BCB-4FDC-9326-75F90DBE59DBQ33748076-18B7D4C5-BD22-4F81-93B8-496AE9BEEE45Q34087616-45D1B80C-8EFE-4252-9A58-56EC386228DAQ34545939-91EC5B10-89D5-43D7-A34D-3E12B1A2A187Q36002988-E5625A90-7042-4267-BA2E-F97F09A37986Q36447954-42701A73-0C71-47A5-88F3-EE0CFBD834EBQ36528769-173FE02A-3EBB-4427-99BA-CB7E724238F6Q36777940-4C726EC2-5E75-4B73-8CD6-1B9E29A13700Q37211143-5B4AA684-5F30-4F6E-B260-64250854449BQ37624589-71D04065-D0DE-41F5-A51D-E84F4E60CB47Q38187661-8BAA33B5-0602-4E5E-988F-F4FF78E0327FQ38196817-541DC2E5-298D-43A3-AA88-833A0C8D5BC1Q39524033-98F63279-7188-406B-A0AE-D5FF7FC0C1BCQ42168945-8E621615-D249-4423-9D8C-0CD92FAE6C44Q42184052-6BFD4560-20B2-4D67-B730-63D7A5A2784AQ47400557-DB2FC6FF-597D-4C43-97FC-5562D31D8CF1Q49788040-FA0A6B6E-139C-460D-BBEA-A573B0C3AF44Q58761484-ED925C9E-9460-459E-B191-AF5111D2D963
P2860
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
@ast
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
@en
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
@nl
type
label
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
@ast
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
@en
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
@nl
prefLabel
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
@ast
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
@en
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
@nl
P2093
P1433
P1476
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.
@en
P2093
Cristina P Vicente
Douglas M Tollefsen
Mauro S G Pavão
P304
P356
10.1182/BLOOD-2004-02-0598
P407
P577
2004-08-17T00:00:00Z